The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $92.35

Today's change+2.16 +2.39%
Updated February 9 2:04 PM EST. Delayed by at least 15 minutes.
 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $92.35

Today's change+2.16 +2.39%
Updated February 9 2:04 PM EST. Delayed by at least 15 minutes.

CME Group Inc Hits New 20-day High

CME Group Inc is up sharply today, rallying (U.S.)$2.16 or 2.39% to (U.S.)$92.35 and setting a new 20-day high. Over the last five days, shares have gained 3.64%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 8.34% during the last year.

Key company metrics

  • Open(U.S.) $89.05
  • Previous close(U.S.) $90.19
  • High(U.S.) $93.26
  • Low(U.S.) $89.05
  • Bid / Ask(U.S.) $92.33 / (U.S.) $92.36
  • YTD % change+1.93%
  • Volume1,710,007
  • Average volume (10-day)2,240,082
  • Average volume (1-month)2,004,498
  • Average volume (3-month)1,623,844
  • 52-week range(U.S.) $81.87 to (U.S.) $100.87
  • Beta0.87
  • Trailing P/E24.70×
  • P/E 1 year forward20.78×
  • Forward PEG1.66×
  • Indicated annual dividend(U.S.) $2.40
  • Dividend yield2.60%
  • Trailing EPS(U.S.) $3.74
Updated February 9 2:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+37.48%

Based on its net profit margin of 37.48%, CME Group Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.50%Sector:FinancialsIndustry:Investment Services
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue850820843841
Total other revenue--------
Total revenue850820843841
Gross profit--------
Total cost of revenue--------
Total operating expense334325335370
Selling / general / administrative249244247258
Research & development--------
Depreciation / amortization57585756
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total28223255
Operating income516495507472
Interest income (expense), net non-operating-28-29-32-29
Gain (loss) on sale of assets--------
Other--------
Income before tax516448524474
Income after tax360265330307
Income tax, total157183193167
Net income360265330307
Total adjustments to net income--------
Net income before extra. items360265330307
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items360265330307
Inc. avail. to common incl. extra. items360265330307
Diluted net income360265330307
Dilution adjustment--00--
Diluted weighted average shares338338337337
Diluted EPS excluding extraordinary itemsvalue per share1.060.780.980.91
Dividends per sharevalue per share0.500.500.502.47
Diluted normalized EPSvalue per share1.060.780.980.91